Nirmatrelvir/Ritonavir Reduces Risk Of Severe COVID-19 For Some Younger Vaccinated Adults With Comorbidities, Study Suggests

July 17, 2023

Healio (7/14, Stulpin) reported, “Paxlovid (nirmatrelvir/ritonavir) lowers the risk for severe COVID-19 among younger vaccinated adults with at least one serious comorbidity, researchers found, although their study did not see the same benefit for patient...